A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease
Identifieur interne : 001A21 ( PascalFrancis/Checkpoint ); précédent : 001A20; suivant : 001A22A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease
Auteurs : A.-M. Ferrandez [France] ; O. BlinSource :
- Behavioural brain research [ 0166-4328 ] ; 1991.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
The aims of the present study were to analyze how L-Dopa allows parkinsonian patients to increase their gait velocity and to compare theseL-Dopa-induced modifications with those achieved by 'consciously' attempting to walk as fast as possible (intentional modulations). The 'intentional modulations' of velocity were also compared with those of healthy elderly subjects. The results showed that parkinsonian patients walked more slowly, with shorter strides and shorter durations of swing phase, and longer durations of stance and double support phases, although no differences were observed for cycle duration
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:92-0148243Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease</title><author><name sortKey="Ferrandez, A M" sort="Ferrandez, A M" uniqKey="Ferrandez A" first="A.-M." last="Ferrandez">A.-M. Ferrandez</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>CNRS Univ. Aix-Marseille II, fac. médecine, IBHOP</s1><s2>Marseille 13388</s2><s3>FRA</s3></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region></placeName></affiliation></author><author><name sortKey="Blin, O" sort="Blin, O" uniqKey="Blin O" first="O." last="Blin">O. Blin</name></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">92-0148243</idno><date when="1991">1991</date><idno type="stanalyst">PASCAL 92-0148243 INIST</idno><idno type="RBID">Pascal:92-0148243</idno><idno type="wicri:Area/PascalFrancis/Corpus">001B58</idno><idno type="wicri:Area/PascalFrancis/Curation">001493</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001A21</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001A21</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease</title><author><name sortKey="Ferrandez, A M" sort="Ferrandez, A M" uniqKey="Ferrandez A" first="A.-M." last="Ferrandez">A.-M. Ferrandez</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>CNRS Univ. Aix-Marseille II, fac. médecine, IBHOP</s1><s2>Marseille 13388</s2><s3>FRA</s3></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region></placeName></affiliation></author><author><name sortKey="Blin, O" sort="Blin, O" uniqKey="Blin O" first="O." last="Blin">O. Blin</name></author></analytic><series><title level="j" type="main">Behavioural brain research</title><title level="j" type="abbreviated">Behav. brain res.</title><idno type="ISSN">0166-4328</idno><imprint><date when="1991">1991</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Behavioural brain research</title><title level="j" type="abbreviated">Behav. brain res.</title><idno type="ISSN">0166-4328</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Basal ganglion</term><term>Dopa</term><term>Gait</term><term>Human</term><term>Locomotion</term><term>Parkinson disease</term><term>Senescence</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term><term>Dopa</term><term>Locomotion</term><term>Allure</term><term>Noyau gris central</term><term>Sénescence</term><term>Homme</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aims of the present study were to analyze how L-Dopa allows parkinsonian patients to increase their gait velocity and to compare theseL-Dopa-induced modifications with those achieved by 'consciously' attempting to walk as fast as possible (intentional modulations). The 'intentional modulations' of velocity were also compared with those of healthy elderly subjects. The results showed that parkinsonian patients walked more slowly, with shorter strides and shorter durations of swing phase, and longer durations of stance and double support phases, although no differences were observed for cycle duration</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0166-4328</s0></fA01><fA02 i1="01"><s0>BBREDI</s0></fA02><fA03 i2="1"><s0>Behav. brain res.</s0></fA03><fA05><s2>45</s2></fA05><fA06><s2>2</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease</s1></fA08><fA11 i1="01" i2="1"><s1>FERRANDEZ (A.-M.)</s1></fA11><fA11 i1="02" i2="1"><s1>BLIN (O.)</s1></fA11><fA14 i1="01"><s1>CNRS Univ. Aix-Marseille II, fac. médecine, IBHOP</s1><s2>Marseille 13388</s2><s3>FRA</s3></fA14><fA14 i1="02"><s1>CHU TImone, clin. maladies neuro-musculaires appareil locomoteur</s1><s2>Marseille</s2><s3>FRA</s3><sZ>2 aut.</sZ></fA14><fA20><s1>177-183</s1></fA20><fA21><s1>1991</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA24 i1="01"><s0>eng</s0></fA24><fA43 i1="01"><s1>INIST</s1><s2>18271</s2><s5>354000022054910080</s5></fA43><fA44><s0>0000</s0></fA44><fA45><s0>38 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>92-0148243</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i2="1"><s0>Behavioural brain research</s0></fA64><fA66 i1="01"><s0>NLD</s0></fA66><fC01 i1="01" l="ENG"><s0>The aims of the present study were to analyze how L-Dopa allows parkinsonian patients to increase their gait velocity and to compare theseL-Dopa-induced modifications with those achieved by 'consciously' attempting to walk as fast as possible (intentional modulations). The 'intentional modulations' of velocity were also compared with those of healthy elderly subjects. The results showed that parkinsonian patients walked more slowly, with shorter strides and shorter durations of swing phase, and longer durations of stance and double support phases, although no differences were observed for cycle duration</s0></fC01><fC02 i1="01" i2="X"><s0>002B17G</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Dopa</s0><s2>NK</s2><s2>FR</s2></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Dopa</s0><s2>NK</s2><s2>FR</s2></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Dopa</s0><s2>NK</s2><s2>FR</s2></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Locomotion</s0></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Locomotion</s0></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Locomoción</s0></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Allure</s0></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Gait</s0></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Marcha</s0></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Noyau gris central</s0></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Basal ganglion</s0></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Núcleo basal</s0></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Sénescence</s0></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Senescence</s0></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Senescencia</s0></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Human</s0></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Maladie dégénérative</s0></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Degenerative disease</s0></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Motricité</s0></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Motricity</s0></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Motricidad</s0></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central</s0></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system</s0></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervioso central</s0></fC07><fN21><s1>149</s1></fN21></pA></standard></inist><affiliations><list><country><li>France</li></country><region><li>Provence-Alpes-Côte d'Azur</li></region></list><tree><noCountry><name sortKey="Blin, O" sort="Blin, O" uniqKey="Blin O" first="O." last="Blin">O. Blin</name></noCountry><country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Ferrandez, A M" sort="Ferrandez, A M" uniqKey="Ferrandez A" first="A.-M." last="Ferrandez">A.-M. Ferrandez</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A21 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001A21 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:92-0148243
|texte= A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease
}}
| This area was generated with Dilib version V0.6.29. |  |